XPhyto Therapeutics Corp.

Recent News

  • Xphyto Therapeutics Oral and Transdermal Cannabis Delivery and Dosage Systems

    Vancouver, British Columbia--(Newsfile Corp. - November 12, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to provide an update on the Company's thin film cannabis delivery and dosage systems in development by XPhyto's wholly owned German subsidiary, Vektor Pharma TF GmbH ("Vektor"). Vektor ...

    2019-11-12 9:00 AM ET
  • XPhyto Therapeutics Signs Term Sheet for German Cannabis Distribution

    Vancouver, British Columbia--(Newsfile Corp. - November 4, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that it has signed a term sheet (the "Term Sheet") with a major cannabis grower and processor (the "Supplier") for exclusive distribution of EU GMP flower, ...

    2019-11-04 3:33 PM ET
  • XPhyto Therapeutics Engages Global Cannabis Expert for German Operations

    Vancouver, British Columbia--(Newsfile Corp. - September 19, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that it has entered into an exclusive two year European consulting agreement (the "Agreement") with Stephen Schroeder, a leading international cannabis expert (the "Consultant"). The Consultant's ...

    2019-09-19 2:05 AM ET
  • XPhyto Therapeutics Signs Exclusive German Cannabis Agreement with Elite Bavarian Brewing & Beverage Institute

    Vancouver, British Columbia--(Newsfile Corp. - September 9, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH ("Bunker"), has entered into an exclusive cannabis research and development agreement (the "Agreement") with the chair of ...

    2019-09-09 2:01 AM ET
  • XPhyto Therapeutics to Acquire German Narcotics Company

    Vancouver, British Columbia--(Newsfile Corp. - August 26, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that it has entered into a definitive share purchase agreement (the "Agreement") with Vektor Pharma TF GmbH ("Vektor"), a German narcotics manufacturer, to acquire 100% of ...

    2019-08-26 12:29 PM ET
  • XPhyto Therapeutics Enters Exclusive Cannabis Research and Development Agreement with the Technical University of Munich

    Vancouver, British Columbia--(Newsfile Corp. - August 14, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Bunker Pflanzenextrakte GmbH ("Bunker"), has entered into an exclusive cannabis research and development agreement (the "R&D Agreement") with the department ...

    2019-08-14 8:00 AM ET
  • XPhyto Therapeutics Commences Trading on the Frankfurt Stock Exchange

    Vancouver, British Columbia--(Newsfile Corp. - August 13, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) ("XPhyto" or the "Company") is pleased to announce that its common shares have commenced trading today on the Frankfurt Stock Exchange (the "FSE") under the ticker symbol "4XT"."Given XPhyto's German cannabis licence and its commitment to ...

    2019-08-13 10:52 AM ET
  • XPhyto Therapeutics Commences Trading on the CSE

    Vancouver, British Columbia--(Newsfile Corp. - August 6, 2019) - XPhyto Therapeutics Corp. (CSE: XPHY) ("XPhyto" or the "Company") is pleased to announce that its common shares will commence trading today on the Canadian Securities Exchange (the "CSE") under the ticker symbol "XPHY"."Trading on the CSE is a significant corporate milestone ...

    2019-08-06 7:30 AM ET